Incidence and Risk of Hypertension in Cancer Patients Treated With Atezolizumab and Bevacizumab: A Systematic Review and Meta-Analysis

PURPOSE: This study aims to inform previous clinical assessments to better understand the total risk of hypertension with atezolizumab and bevacizumab (hereafter referred to as “A-B”) in cancer patients, and reduce future incidence of hypertension-related cardiovascular complications. METHODS: Datab...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Linhan, Tan, Xiaoxia, Li, Jun, Li, Yaling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8546244/
https://www.ncbi.nlm.nih.gov/pubmed/34712609
http://dx.doi.org/10.3389/fonc.2021.726008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8546244/
https://www.ncbi.nlm.nih.gov/pubmed/34712609
http://dx.doi.org/10.3389/fonc.2021.726008

Ejemplares similares